Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study

References

• World Health Organization. 2023 [accessed 2023 Nov 8]. https://covid19.who.int/.
   Google Scholar
• Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–7. doi:10.1038/s41579-022-00846-2.
   PubMed Web of Science ®Google Scholar
• Qin S, Li Y, Wang L, Zhao X, Ma X, Gao GF. Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey. Emerg Microbes Infect. 2023;12(2):2258232. doi:10.1080/22221751.2023.2258232.
   PubMed Web of Science ®Google Scholar
• Phillips S, Williams MA. Confronting our next national health disaster - Long-Haul Covid. N Engl J Med. 2021;385(7):577–9. doi:10.1056/NEJMp2109285.
   PubMed Web of Science ®Google Scholar
• Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, Di Gessa G. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi:10.1038/s41467-022-30836-0.
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud‐Kouhanjani M. et al. Long COVID syndrome-associated brain fog. J Med Virol. 2022;94(3):979–84. doi:10.1002/jmv.27404.
   PubMed Web of Science ®Google Scholar
• Nehme M, Braillard O, Salamun J, Jacquerioz F, Courvoisier DS, Spechbach H, Guessous I. Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J Gen Intern Med. 2022;37(6):1585–8. doi:10.1007/s11606-022-07443-2.
   PubMed Web of Science ®Google Scholar
• Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12422. doi:10.3390/ijerph191912422.
   PubMed Web of Science ®Google Scholar
• Marin-Hernandez D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol. 2021;93(1):64–5. doi:10.1002/jmv.26120.
   PubMed Web of Science ®Google Scholar
• Conlon A, Ashur C, Washer L, Eagle KA, Hofmann Bowman MA. Impact of the influenza vaccine on COVID-19 infection rates and severity. Am J Infect Control. 2021;49(6):694–700. doi:10.1016/j.ajic.2021.02.012.
   PubMed Web of Science ®Google Scholar
• Lee CH, Pinho MP, Buckley PR, Woodhouse IB, Ogg G, Simmons A, Napolitani G, Koohy H. Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains. Front Immunol. 2020;11:579480. doi:10.3389/fimmu.2020.579480.
   PubMed Web of Science ®Google Scholar
• Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M, Andrews N, Ramsay M, Lopez Bernal J. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021;50(4):1124–33. doi:10.1093/ije/dyab081.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coadministration of seasonal inactivated influenza and COVID-19 vaccines: interim guidance, https://apps.who.int/iris/handle/10665/346897; 2021 [accessed on 8 November 2023].
   Google Scholar
• Janssen C, Mosnier A, Gavazzi G, Combadière B, Crépey P, Gaillat J, Launay O, Botelho-Nevers E. Coadministration of seasonal influenza and COVID-19 vaccines: a systematic review of clinical studies. Hum Vaccin Immunother. 2022;18(6):2131166. doi:10.1080/21645515.2022.2131166.
   PubMed Web of Science ®Google Scholar
• Borsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, Schaan B, Stuck S, Zuber S. Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int J Epidemiol. 2013;42(4):992–1001. doi:10.1093/ije/dyt088.
   PubMed Web of Science ®Google Scholar
• Börsch-Supan A. Survey of health, ageing and retirement in Europe (SHARE) wave 8. Release version: 8.0.0. SHARE-ERIC. Data set; 2022. doi:10.6103/SHARE.w8.800.
   Google Scholar
• Börsch-Supan A. Survey of health, ageing and retirement in Europe (SHARE) wave 8. COVID-19 survey 1. Release version: 8.0.0. SHARE-ERIC. Data set; 2022. doi:10.6103/SHARE.w8ca.800.
   Google Scholar
• Börsch-Supan A. Survey of health, ageing and retirement inEurope (SHARE) wave 9. COVID-19 survey 2. Release version: 8.0.0. SHARE-ERIC. Data set; 2022. doi:10.6103/SHARE.w9ca.800.
   Google Scholar
• World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus; 2021 Oct6 [accesssed 2024 Apr7]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
   Google Scholar
• Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, Ward H, Elliott P. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi:10.1038/s41467-022-29521-z.
   PubMed Web of Science ®Google Scholar
• Wilk P, Moran V, Alperin MNP, Bohn T, Fagherazzi G, Zeegers MP, Ruiz-Castell M. The role of multimorbidity and socio-economic characteristics as potential risk factors for long covid: evidence from the multilevel analysis of the survey of health, ageing and retirement in Europe’s corona surveys (2020–2021). Age Ageing. 2023;52(12):afad225. doi:10.1093/ageing/afad225.
   PubMed Web of Science ®Google Scholar
• Prince MJ, Reischies F, Beekman AT, Fuhrer R, Jonker C, Kivela SL, Lawlor BA, Lobo A, Magnusson H, Fichter M. et al. Development of the EURO–D scale – a European union initiative to compare symptoms of depression in 14 European centres. Br J Psychiatry. 1999;174(4):330–8. doi:10.1192/bjp.174.4.330.
   PubMedGoogle Scholar
• Zhong C, Wang G, Xu T, Zhu Z, Guo D, Zheng X, Wang A, Bu X, Peng H, Chen J. et al. Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke. Neurology. 2019;93(18):1675–85. doi:10.1212/WNL.0000000000008389.
   Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr., D’Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72. discussion 207-112. doi: 10.1002/sim.2929.
   PubMed Web of Science ®Google Scholar
• Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154–62. doi:10.1016/j.bbi.2022.04.013.
   PubMed Web of Science ®Google Scholar
• Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461–7. doi:10.1038/s41591-022-01840-0.
   PubMed Web of Science ®Google Scholar
• Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, Peligro PJ, Casimiro M, Guerrero JJ, Gellaco MML. et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624. doi:10.1016/j.eclinm.2022.101624.
   PubMedGoogle Scholar
• Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, Rescigno M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676–8. doi:10.1001/jama.2022.11691.
   PubMed Web of Science ®Google Scholar
• Tofarides AG, Christaki E, Milionis H, Nikolopoulos GK. Effect of vaccination against SARS-CoV-2 on long COVID-19: a narrative review. Life (Basel). 2022;12(12):2057. doi:10.3390/life12122057.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, Green J, Quintana A, Druckman J, Baum MA. et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5(10):e2238804. doi:10.1001/jamanetworkopen.2022.38804.
   PubMed Web of Science ®Google Scholar
• Veronese N, Smith L, Di Gennaro F, Bruyère O, Yang L, Demurtas J, Maggi S, Sabico S, Al-Daghri NM, Barbagallo M. et al. Influenza vaccination and COVID-19 outcomes in people older than 50 years: data from the observational longitudinal SHARE study. Vaccines. 2022;10(6):899. doi:10.3390/vaccines10060899.
   Web of Science ®Google Scholar
• Debisarun PA, Struycken P, Domínguez-Andrés J, Moorlag SJCFM, Taks E, Gssling KL, Ostermann PN, Müller L, Schaal H, Oever JT, et al. The effect of influenza vaccination on trained immunity: impact on COVID-19. medRxiv. 2020. doi:10.1101/2020.10.14.20212498.
   Google Scholar
• Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013;34(9):431–9. doi:10.1016/j.it.2013.04.004.
   PubMed Web of Science ®Google Scholar
• Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59(2):2102245. doi:10.1183/13993003.02245-2021.
   PubMed Web of Science ®Google Scholar